137 related articles for article (PubMed ID: 14742245)
1. Higher vessel densities in retinoblastoma with local invasive growth and metastasis.
Rössler J; Dietrich T; Pavlakovic H; Schweigerer L; Havers W; Schüler A; Bornfeld N; Schilling H
Am J Pathol; 2004 Feb; 164(2):391-4. PubMed ID: 14742245
[TBL] [Abstract][Full Text] [Related]
2. Nm23 expression in retinoblastoma.
Krishnakumar S; Lakshmi A; Shanmugam MP; Vanitha K; Biswas J
Ocul Immunol Inflamm; 2004 Jun; 12(2):127-35. PubMed ID: 15512982
[TBL] [Abstract][Full Text] [Related]
3. Inhibitory effect of bevacizumab on the angiogenesis and growth of retinoblastoma.
Lee SY; Kim DK; Cho JH; Koh JY; Yoon YH
Arch Ophthalmol; 2008 Jul; 126(7):953-8. PubMed ID: 18625942
[TBL] [Abstract][Full Text] [Related]
4. Heterogeneous tumor vasculature in retinoblastoma: implications for vessel targeting therapy.
Jockovich ME; Piña Y; Alegret A; Cebulla C; Feuer W; Murray TG
Retina; 2008 Mar; 28(3 Suppl):S81-6. PubMed ID: 18317352
[TBL] [Abstract][Full Text] [Related]
5. Blood vessel maturation in retinoblastoma tumors: spatial distribution of neovessels and mature vessels and its impact on ocular treatment.
Piña Y; Boutrid H; Schefler A; Dubovy S; Feuer W; Jockovich ME; Murray TG
Invest Ophthalmol Vis Sci; 2009 Mar; 50(3):1020-4. PubMed ID: 18952925
[TBL] [Abstract][Full Text] [Related]
6. Retinoblastoma tumor vessel maturation impacts efficacy of vessel targeting in the LH(BETA)T(AG) mouse model.
Jockovich ME; Bajenaru ML; Piña Y; Suarez F; Feuer W; Fini ME; Murray TG
Invest Ophthalmol Vis Sci; 2007 Jun; 48(6):2476-82. PubMed ID: 17525173
[TBL] [Abstract][Full Text] [Related]
7. Expression of Angiogenic Factors in Invasive Retinoblastoma Tumors Is Associated With Increase in Tumor Cells Expressing Stem Cell Marker Sox2.
Garcia JR; Gombos DS; Prospero CM; Ganapathy A; Penland RL; Chévez-Barrios P
Arch Pathol Lab Med; 2015 Dec; 139(12):1531-8. PubMed ID: 26619025
[TBL] [Abstract][Full Text] [Related]
8. Correlation of overexpression of HMGA1 and HMGA2 with poor tumor differentiation, invasion, and proliferation associated with let-7 down-regulation in retinoblastomas.
Mu G; Liu H; Zhou F; Xu X; Jiang H; Wang Y; Qu Y
Hum Pathol; 2010 Apr; 41(4):493-502. PubMed ID: 20004941
[TBL] [Abstract][Full Text] [Related]
9. Expression of vascular endothelial growth factor in retinoblastoma.
Areán C; Orellana ME; Abourbih D; Abreu C; Pifano I; Burnier MN
Arch Ophthalmol; 2010 Feb; 128(2):223-9. PubMed ID: 20142546
[TBL] [Abstract][Full Text] [Related]
10. [Relationship between vasculogenic mimicry and clinical pathological characters in retinoblastoma].
Niu YJ; Liu FL; Yang Y; Yuan CY
Zhonghua Yan Ke Za Zhi; 2009 Apr; 45(4):318-22. PubMed ID: 19575963
[TBL] [Abstract][Full Text] [Related]
11. De novo intraocular retinoblastoma development after chemotherapy in patients with hereditary retinoblastoma.
Schueler AO; Anastassiou G; Jurklies C; Havers W; Wieland R; Bornfeld N
Retina; 2006 Apr; 26(4):425-31. PubMed ID: 16603962
[TBL] [Abstract][Full Text] [Related]
12. VEGF-targeted RNA interference suppresses angiogenesis and tumor growth of retinoblastoma.
Jia RB; Zhang P; Zhou YX; Song X; Liu HY; Wang LZ; Luo M; Lu J; Ge SF; Fan XQ
Ophthalmic Res; 2007; 39(2):108-15. PubMed ID: 17284938
[TBL] [Abstract][Full Text] [Related]
13. Clinico-pathological correlations of fatty acid synthase expression in retinoblastoma: an Indian cohort study.
Vandhana S; Deepa PR; Jayanthi U; Biswas J; Krishnakumar S
Exp Mol Pathol; 2011 Feb; 90(1):29-37. PubMed ID: 21111730
[TBL] [Abstract][Full Text] [Related]
14. Vascular invasion and potential for tumor angiogenesis and metastasis in gastric carcinoma.
Maehara Y; Kabashima A; Koga T; Tokunaga E; Takeuchi H; Kakeji Y; Sugimachi K
Surgery; 2000 Sep; 128(3):408-16. PubMed ID: 10965312
[TBL] [Abstract][Full Text] [Related]
15. Tumour angiogenesis as a prognostic factor for disease dissemination in retinoblastoma.
Marback EF; Arias VE; Paranhos A; Soares FA; Murphree AL; Erwenne CM
Br J Ophthalmol; 2003 Oct; 87(10):1224-8. PubMed ID: 14507753
[TBL] [Abstract][Full Text] [Related]
16. Quantitative analysis of proliferation, apoptosis, and angiogenesis in retinoblastoma and their association with the clinicopathologic parameters.
Kerimoğglu H; Kiratli H; Dinçtürk AA; Söylemezoğlu F; Bilgiç S
Jpn J Ophthalmol; 2003; 47(6):565-71. PubMed ID: 14636846
[TBL] [Abstract][Full Text] [Related]
17. Clinical pathologic study of a cohort of patients with retinoblastoma from a developing country.
Orellana ME; Fernandes BF; Arean C; Pifano I; Al-Kandari A; Burnier MN
J Pediatr Ophthalmol Strabismus; 2009; 46(5):294-9. PubMed ID: 19791727
[TBL] [Abstract][Full Text] [Related]
18. [HIF-1alpha, HPSE and VEGF promote malignant progression of retinoblastoma].
Wang XL; Niu YJ; Ma JM
Zhonghua Yan Ke Za Zhi; 2010 Feb; 46(2):140-4. PubMed ID: 20388348
[TBL] [Abstract][Full Text] [Related]
19. Cavitary changes in retinoblastoma: relationship to chemoresistance.
Mashayekhi A; Shields CL; Eagle RC; Shields JA
Ophthalmology; 2005 Jun; 112(6):1145-50. PubMed ID: 15885779
[TBL] [Abstract][Full Text] [Related]
20. Histopathological features and P-glycoprotein expression in retinoblastoma.
Filho JP; Correa ZM; Odashiro AN; Coutinho AB; Martins MC; Erwenne CM; Burnier MN
Invest Ophthalmol Vis Sci; 2005 Oct; 46(10):3478-83. PubMed ID: 16186322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
